Bank Of America Corp Vir Biotechnology, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 851,774 shares of VIR stock, worth $8.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

851,774

Previous 1,136,354 25.04%

Holding current value

$8.66 Million

Previous $11.5 Million 34.15%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.63 - $12.66 $2.17 Million - $3.6 Million	-284,580 Reduced 25.04%	851,774 $7.58 Million
Q1 2024 May 15, 2024	BUY	$8.6 - $11.9 $8.46 Million - $11.7 Million	984,009 Added 645.91%	1,136,354 $11.5 Million
Q4 2023 Feb 14, 2024	SELL	$7.76 - $10.29 $1.46 Million - $1.94 Million	-188,557 Reduced 55.31%	152,345 $1.53 Million
Q2 2023 Aug 14, 2023	SELL	$23.2 - $27.29 $6.24 Million - $7.34 Million	-268,813 Reduced 44.09%	340,902 $8.36 Million
Q1 2023 May 12, 2023	BUY	$22.26 - $30.85 $2.22 Million - $3.08 Million	99,862 Added 19.59%	609,715 $14.2 Million
Q4 2022 Feb 10, 2023	BUY	$19.96 - $28.22 $1.47 Million - $2.08 Million	73,763 Added 16.91%	509,853 $12.9 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $4.37 Million - $7.44 Million	239,146 Added 121.43%	436,090 $8.41 Million
Q2 2022 Aug 12, 2022	SELL	$19.08 - $26.7 $5.8 Million - $8.12 Million	-304,235 Reduced 60.7%	196,944 $5.02 Million
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $4.18 Million - $7.89 Million	197,274 Added 64.91%	501,179 $12.9 Million
Q4 2021 Feb 08, 2022	BUY	$30.97 - $54.03 $3.67 Million - $6.4 Million	118,522 Added 63.93%	303,905 $12.7 Million
Q3 2021 Nov 15, 2021	SELL	$34.9 - $54.54 $1.69 Million - $2.63 Million	-48,291 Reduced 20.67%	185,383 $8.07 Million
Q2 2021 Sep 13, 2021	BUY	$38.75 - $51.0 $9.05 Million - $11.9 Million	233,674 New	233,674 $11 Million

Others Institutions Holding VIR

# of Institutions

222

Shares Held

85.8M

Call Options Held

231K

Put Options Held

132K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.35B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Vir Biotechnology, Inc. Transaction History